Some of the nation’s top medical schools cracked down on professors who give paid promotional talks for drugmakers last year, and the firms themselves cut back on such spending in the wake of mounting scrutiny. ProPublica first published its Dollars for Docs database in October 2010 listing payments to doctors from seven drug companies. When we updated it this September — with data from five additional companies — spending by some of the firms was down.